All About SCA7

SCA7 or Spinocerebellar Ataxia 7 is a rare neuromuscular disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. Ali Hamedani on September 5th, 2023. In "All About SCA7", he gave an overview of the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. For more information on Ataxia, please visit our website: https://www.ataxia.org Become a Free NAF member! https://bit.ly/JoinNAF Follow us on Social Media! NAF Facebook:   / ataxiafounda.  . NAF Twitter:   / naf_ataxia   NAF Instagram:   / ataxiafound.  . Ataxia Subreddit:   / ataxia   About the Speaker: Ali G Hamedani, MD, MHS is an Assistant Professor of Neurology, Ophthalmology, and Epidemiology and director of the Penn Ataxia Clinic at the University of Pennsylvania. He obtained his B.S. in Biology from Yale University and his M.D. from the University of Maryland School of Medicine. He also holds a master's degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health and conducts epidemiologic research related to visual impairment in aging and neurodegenerative disease. After completing his neurology residency and fellowships in neuro-ophthalmology and movement disorders at the University of Pennsylvania, Dr. Hamedani joined the faculty in 2018. In addition to directing the ataxia clinic, he maintains a neuro-ophthalmology clinic that is focused on patients with visual symptoms due to neurodegenerative disease, including retinal and optic nerve disease associated with certain spinocerebellar ataxias. About the Series: NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.